Quantitative Systematic Strategies’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Quantitative Systematic Strategies’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-8,121	Closed	-$333K	–	708
2018 Q4	$333K	Buy	+8,121	New	+$304K	0.07%	375
2018 Q3	–	Sell	-4,499	Closed	-$203K	–	842
2018 Q2	$203K	Buy	+4,499	New	+$205K	0.04%	556
2017 Q4	–	Sell	-7,635	Closed	-$237K	–	686
2017 Q3	$237K	Buy	+7,635	New	+$215K	0.06%	380

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Quantitative Systematic Strategies's GBT Position: Q1 2019 in Review

Quantitative Systematic Strategies sold out of Global Blood Therapeutics, Inc. (GBT) in Q1 2019, closing a stake of 8,121 shares — an estimated $333K sold.

Quantitative Systematic Strategies first reported a position in GBT in Q3 2017 and held it in 3 quarters. The position peaked at $333K in Q4 2018. 201 funds tracked by Wall St. Rank hold GBT as of Q1 2019.

Quantitative Systematic Strategies reported no remaining Global Blood Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
Quantitative Systematic Strategies sold 8,121 Global Blood Therapeutics, Inc. shares in Q1 2019, an estimated $333K.
Quantitative Systematic Strategies first reported a position in Global Blood Therapeutics, Inc. in Q3 2017 and held it in 3 quarters.
Quantitative Systematic Strategies's Global Blood Therapeutics, Inc. position peaked at $333K in Q4 2018.
201 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2019, filed 15 Apr 2019.